| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/24/2006 | CA2255447C Percutaneous absorption type preparation |
| 01/24/2006 | CA2248576C Method of forming articles and patterning surfaces via capillary micromolding |
| 01/24/2006 | CA2186042C Cosmetic or dermopharmaceutical patch containing in an anhydrous polymeric matrice at least one active component, especially unstable in oxidative media, and at least one water absorbing agent |
| 01/24/2006 | CA2119250C Blended lipid vesicles |
| 01/19/2006 | WO2006007514A2 Methods for producing functional antigen presenting dentritic cells using biodegradable microparticles for delivery of antigenic materials |
| 01/19/2006 | WO2006007487A2 Cosmetic compositions and methods containing a tanning agent and liposome-enscapsulated ursolic acid |
| 01/19/2006 | WO2006007372A2 Drug delivery product and methods |
| 01/19/2006 | WO2006007354A2 A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device |
| 01/19/2006 | WO2006007351A2 Squeeze controlled oral dosage form |
| 01/19/2006 | WO2006007332A1 Oral delivery of peptide pharmaceutical compositions |
| 01/19/2006 | WO2006007323A2 Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents |
| 01/19/2006 | WO2006007183A1 Binary thermo-gelling composition |
| 01/19/2006 | WO2006007136A2 Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease |
| 01/19/2006 | WO2006007095A2 High ibuprofen content granules and their preparation and use |
| 01/19/2006 | WO2006006998A1 Calcium peroxyphosphates and use thereof in dental compositions |
| 01/19/2006 | WO2006006929A1 Infusion and injection solution of levodopa |
| 01/19/2006 | WO2006006861A1 Composition and method for medical imaging of body cavities |
| 01/19/2006 | WO2006006691A2 Solid dispersion of a p38 map kinase inhibitor |
| 01/19/2006 | WO2006006674A1 Pth-containing preparation for transmucosal administration |
| 01/19/2006 | WO2006006603A1 Liposome allowing the discharge of substance entrapped therein from endosome |
| 01/19/2006 | WO2006006595A1 Medicinal composition for oral use |
| 01/19/2006 | WO2006006035A2 A safe delivery system for agriculturally active material |
| 01/19/2006 | WO2006006021A2 Stabilized pharmaceutical compositions of preferably a statin |
| 01/19/2006 | WO2006005910A2 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose |
| 01/19/2006 | WO2006005853A1 S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor |
| 01/19/2006 | WO2006005845A1 Spray composition comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non volatile oily phase |
| 01/19/2006 | WO2006005844A1 Pressurized foaming composition for topical treatment of psoriasis |
| 01/19/2006 | WO2006005843A1 Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology |
| 01/19/2006 | WO2006005842A1 Pharmaceutical composition comprising an ointment and two solubilized active principles |
| 01/19/2006 | WO2006005794A1 A delivery system |
| 01/19/2006 | WO2006005581A2 A composition comprising a pharmacologically active agent coupled to a target cell specific component, and a saponin |
| 01/19/2006 | WO2006005578A2 Solid pharmaceutical composition comprising mirtazapine |
| 01/19/2006 | WO2006005512A1 Granules for controlled release of tamsulosin |
| 01/19/2006 | WO2006005287A2 Capsule for releasing agents contained therein at defined points in a body |
| 01/19/2006 | WO2005115331A3 Enteric solid oral dosage form of bisphosphonate containing a chelating agent |
| 01/19/2006 | WO2005107701A8 Remote control release of material encapsulated in polyelectrolyte multilayer microcapsules |
| 01/19/2006 | WO2005102307A3 Beneficial effects of increasing local blood flow |
| 01/19/2006 | WO2005082379A8 Myocardial perfusion imaging using adenosine receptor agonists |
| 01/19/2006 | WO2005079511A3 SYSTEM IMMUNE ACTIVATION METHOD USING NON CpG NUCLEIC ACIDS |
| 01/19/2006 | WO2005065317A3 Effervescent oral fentanyl dosage form |
| 01/19/2006 | WO2005056576A3 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 01/19/2006 | WO2005009408A3 Sustained release dosage forms of anesthetics for pain management |
| 01/19/2006 | US20060015089 Catheter and method of fluid removal from a body cavity |
| 01/19/2006 | US20060015088 Arrangement for remote-controlled release of active ingredients |
| 01/19/2006 | US20060015083 Absorbent hydrogels |
| 01/19/2006 | US20060015077 Transdermal patches having a siliconic adhesive matrix stabilized with methacrylic copolymers |
| 01/19/2006 | US20060015054 External plaster containing 4-biphenylacetic acid |
| 01/19/2006 | US20060014982 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 01/19/2006 | US20060014861 Compositions and methods relating to an adhesive composition |
| 01/19/2006 | US20060014834 For treatment of skin disorders (acne); solubilized in alcohol |
| 01/19/2006 | US20060014832 Highly pure bases of 3,3-dipheyl propylamine monoesters |
| 01/19/2006 | US20060014788 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/19/2006 | US20060014786 Opthalmic pharmaceutical compositions and methods for treating ocular inflammation |
| 01/19/2006 | US20060014734 Immediate release pharmaceutical formulation |
| 01/19/2006 | US20060014730 Ansamycin formulations and methods for producing and using same |
| 01/19/2006 | US20060014713 Immunostimulatory oligonucleotide multimers |
| 01/19/2006 | US20060014699 Aqueous pharmaceutical formulaton comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism |
| 01/19/2006 | US20060014695 Hpma-polyamine conjugates and uses therefore |
| 01/19/2006 | US20060014681 Three-dimensional structure of complement receptor type 2 and uses thereof |
| 01/19/2006 | US20060013904 Treatment method comprising administering feverfew to oral mucosal tissues in solid or semi-solid form |
| 01/19/2006 | US20060013898 Aromatherapy system |
| 01/19/2006 | US20060013896 Methods of treating acute pain using diclofenac |
| 01/19/2006 | US20060013895 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes |
| 01/19/2006 | US20060013891 increase water solubility with two co-grinding auxiliary substances, one is amino acid and one is ammonium glycyrrhizate; beeswax with greater bioavailability; as immunostimulants, bactericide and bacteriostatic activities, viricide and mycostatic activities, antiinflammatory agent, wound healing agent |
| 01/19/2006 | US20060013888 using monoterpenes such as limonene; encapsulation; soft capsules |
| 01/19/2006 | US20060013887 Delayed release carnitine |
| 01/19/2006 | US20060013886 Injectable microspheres |
| 01/19/2006 | US20060013885 Water soluble chitosan nanoparticle for delivering an anticancer agent and preparing method thereof |
| 01/19/2006 | US20060013884 Humidity-dependent antibacterial powdery composition, process for producing the same, humidity-dependent antibacterial food storing article and method of storing food |
| 01/19/2006 | US20060013883 Poloxamer and poloxamine compositions for nucleic acid delivery |
| 01/19/2006 | US20060013882 Tri-block copolymers for nanosphere-based drug delivery |
| 01/19/2006 | US20060013881 Hydrophilic antimicrobial composition for an air conditioner evaporator of a vehicle |
| 01/19/2006 | US20060013880 Formulation stabilizer for proton pump inhibitors |
| 01/19/2006 | US20060013879 Gel composition and methods |
| 01/19/2006 | US20060013878 Process for forming a gel containing an ingredient therein |
| 01/19/2006 | US20060013877 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 01/19/2006 | US20060013876 Novel floating dosage form |
| 01/19/2006 | US20060013875 Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 01/19/2006 | US20060013874 Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one |
| 01/19/2006 | US20060013873 Bioadhesive dosage form of steroids |
| 01/19/2006 | US20060013872 Pharmaceutical compositions comprising ibuprofen and domperidone |
| 01/19/2006 | US20060013871 Intimate coating of ibuprofen with poloxamers to enhance aqueous dissolution |
| 01/19/2006 | US20060013870 Pharmaceutical compositions of hops resins |
| 01/19/2006 | US20060013869 Electrospun amorphous pharmaceutical compositions |
| 01/19/2006 | US20060013868 Controlled release preparation |
| 01/19/2006 | US20060013867 Medical devices and materials containing isobutylene copolymer |
| 01/19/2006 | US20060013866 Transdermal drug delivery formulations with optimal amounts of vasodilators therein |
| 01/19/2006 | US20060013865 Transdermal patch for external use comprising fentanyl |
| 01/19/2006 | US20060013864 Transmucosal pharmacuetical administration form |
| 01/19/2006 | US20060013862 Onychomycosis: a new process for cure |
| 01/19/2006 | US20060013861 Functional foods comprising flavonoids and tocotrienols and methods thereof |
| 01/19/2006 | US20060013859 Drug delivery system using subconjunctival depot |
| 01/19/2006 | US20060013852 Use of organic compounds |
| 01/19/2006 | US20060013851 Therapeutic polyanhydride compounds for drug delivery |
| 01/19/2006 | US20060013850 Electropolymerizable monomers and polymeric coatings on implantable devices prepared therefrom |
| 01/19/2006 | US20060013837 Flavour compositions |
| 01/19/2006 | US20060013836 Dissolving ixabepilone in tert-butanol and water, and then vacuum drying to lypophilize; 7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-4-aza-7-oxabicyclo[14.1.0]heptadecane-5,9-dione is ixabepilone |
| 01/19/2006 | US20060013835 Longitudinal body with polymeric coating; triamcinolone acetonide; drug delivery to eye |
| 01/19/2006 | US20060013834 Room temperature stable aqueous liquid pharmaceutical composition |
| 01/19/2006 | US20060013820 Antigen delivery vectors and constructs |